StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Sulfamoxol

Sulfamoxole

HCID 12894
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
729-99-7
Standard-SMILES
Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C
InChIKey
CYFLXLSBHQBMFT-UHFFFAOYSA-N
Summenformel
C11H13N3O3S
Durchschnittliche Molmasse
267,31 g/mol
Monoisotopische Masse
267,06776246

Überblick

Sulfamoxole is a sulfonamide antibiotic in which 4-aminobenzenesulfonic acid and 4,5-dimethyl-1,3-oxazol-2-amine have combined to form the sulfonamide bond. It has a role as an antimicrobial agent and a drug allergen. It is a sulfonamide, an oxazole and a sulfonamide antibiotic.

Namen und Bezeichner

Bevorzugter Name
Sulfamoxole
IUPAC
4-amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide
Lokaler Name
Sulfamoxol
Englischer Name
SULFAMOXOL
Summenformel
C11H13N3O3S
Molmasse
267.3

Namen und Synonyme

SULFAMOXOLE729-99-7SulfamoxolSulphamoxoleSulfamoxolumSulfadimethyloxazoleOxasulfaSulfuno4-Amino-N-(4,5-dimethyl-2-oxazolyl)benzenesulfonamide4,5-Dimethyl-2-sulfanilamidooxazole4-Amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamideN1-(4,5-Dimethyl-2-oxazolyl)sulfanilamide
Weitere Namen anzeigen
NuprinSulfabutinSulfamoxol-d4Sulfamocol-D4SdmoSulfanosulfonoSulfune
2-(p-Aminobenzenesulfonamido)-4,5-dimethyloxazolep-Aminobenzenesulfonyl-2-amino-4,5-dimethyloxazoleDTXSID50236172-(p-Aminobenzolsulfonamido)-4,5-dimethyloxazolBenzenesulfonamide, 4-amino-N-(4,5-dimethyl-2-oxazolyl)-N(sup 1)-(4,5-Dimethyl-2-oxazolyl)sulfanilamideNSC-683535HGG82XE020

Datenbank-Bezeichner

CAS
729-99-7
PubChem CID
12894
DTXSID
DTXSID5023617

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,3
Polarare Oberfläche (TPSA)
107 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
3
Schwere Atome
18
Formalladung
0
Komplexität
373

Experimentelle und physikochemische Eigenschaften

Drugs · 3 Einträge

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antibiotics (Sulfonamide)

SpringerMaterials PropertiesFusion temperature
LogP0.2
Human DrugsPharmaceuticals
Melting Point185 °C
Physical DescriptionSolid

Physikochemische Eigenschaften

Schmelzpunkt
197 · 197-199℃
Siedepunkt
481 · 481.0±47.0 °C(Predicted)
Dichte
1.3786 g/cm3 · 1.3786 g/cm3
Brechungsindex
1.663 · 1.6630 (estimate)
storage temp.
Refrigerator, Under Inert Atmosphere

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Hazard Classes and CategoriesSkin Sens. 1 (100%)

Sicherheitsdaten

wgk
2
RTECS-Nr.
WO9150000
risk_code
43
Toxizität
LD50 in mice, rats (g/kg): >10.0, >12.5 orally; 1.80, ~2.50 i.p. (Lagler)
hazard_code
Xi
safety_code
36/37

Chemie und Industrie

Pharmakologische Informationen

ATC CodeJ - Antiinfectives for systemic use
Pharmacodynamics · 1 Eintrag

Sulfamoxole is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of <i>p</i>-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.

Mechanism of Action · 1 Eintrag

Sulfamoxole is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. This enzyme is needed for the proper processing of para-aminobenzoic acid (PABA) which is essential for folic acid synthesis. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.

MeSH Pharmacological ClassificationSubstances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Cellular LocationsMembrane

Verwendung und Herstellung

Use ClassificationPharmaceuticals

Anwendungen

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
ChEMBL
CHEMBL2105399
ChEBI
CHEBI:55548
UNII
HGG82XE020
EC Number
211-982-7
Nikkaji
J6.953A
Löslichkeit
DMSO (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
7.4 · pKa 7.40 (Uncertain)
Farbe
Off-White to Pale Yellow
Wasserlöslichkeit
961 mg/L · 961mg/L(20 ºC)
Merck
13 · 13,9009
BRN
248434 · 248434
InChI
InChI=1S/C11H13N3O3S/c1-7-8(2)17-11(13-7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6H,12H2,1-2H3,(H,13,14)
InChIKey
CYFLXLSBHQBMFT-UHFFFAOYSA-N
SMILES
C1(S(NC2=NC(C)=C(C)O2)(=O)=O)=CC=C(N)C=C1

VerwendenSilversulfadiazine and Sulfamoxol are common drugs in treatment of bacterial disease.

Ergänzende Hinweise

DefinitionChEBI: A sulfonamide antibiotic in which 4-aminobenzenesulfonic acid and 4,5-dimethyl-1,3-oxazol-2-amine have combined to form the sulfonamide bond.